Tufts CSDD shows multi-million dollar benefits of Translational Pharmaceutics
The outcomes from this research indicate that Translational Pharmaceutics can create substantial time savings and financial benefits to pharma and biotech companies
Breaking News
MIT spinout designs gentle process for billions of engineered cells in minutes
Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect system using continuous fluid flow combined ...
3i builds single-use bioprocessing platform using three acquisitions
The UK-based company has acquired Cellon, Silicone Altimex and TBL Performance Plastics to establish a platform serving ...
Genopis plans plasmid CDMO business launch
Helixmith US-based spinout has capitalised on its pDNA manufacturing experience with plans to launch a CDMO business
Integrated solutions offer fast-track development for biopharmaceuticals
At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...
Porton Pharma Solutions opens new fermentation pilot lab in China
New fermentation capacity has enabled Porton to deliver kilogram level enzyme powder preparation to meet pilot-scale ...
Evotec agrees to give US Merck access to facility of the future
MSD has paid $15m to gain access to Just–Evotec Biologics’ J.POD Washington facility that conducts small, ...
Medical cannabis made in Italy
Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...
Collaboration aims to commercialise regenerative medicine technology
Hitachi Chemical Advanced Therapeutics Solutions and Ori Biotech have agreed to work together to progress Ori’s ...
NIBRT launches first online biopharma manufacturing programme
NIBRT Online Academy is online training that has been designed to assist with the skills and career development of ...
Optimising viral vector production for biologics
To overcome existing challenges in viral vector production, Belgium-based Univercells has worked to develop an ...
Future market dynamics and opportunities in immuno-oncology
Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts ...
Lonza reveals process development roadmap for cell and gene therapies
Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...
Eli Lilly makes $1.1bn biopharma acquisition
Pharma giant Eli Lilly has agreed to acquire chronic skin condition-focused biopharma Dermira
US gene therapy CDMO enters virus manufacturing partnership
Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production
In Brief
Most Popular in Biotechnology
- Lonza reveals process development roadmap for cell and gene therapies
- 3i builds single-use bioprocessing platform using three acquisitions
- Optimising viral vector production for biologics
- Evotec agrees to give US Merck access to facility of the future
- Integrated solutions offer fast-track development for biopharmaceuticals
Featured Companies
Reports
